Endocrinologist News and Research RSS Feed - Endocrinologist News and Research

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

GSK today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout the U.S. [More]
Portable, microchip-based test for diagnosing type-1 diabetes

Portable, microchip-based test for diagnosing type-1 diabetes

An inexpensive, portable, microchip-based test for diagnosing type-1 diabetes could improve patient care worldwide and help researchers better understand the disease, according to the device's inventors at the Stanford University School of Medicine. [More]
Global toolkit for managing menopause

Global toolkit for managing menopause

Created at Monash University, the world's first toolkit is designed for GPs to use with women from the age of 40. Thought to be the first of its kind, researchers say the toolkit has the potential to help manage menopausal conditions for women globally. [More]
Patients with Cushing’s syndrome experience significant weight loss while taking oral medication

Patients with Cushing’s syndrome experience significant weight loss while taking oral medication

Sinai Hospital of Baltimore endocrinologist, Henry G. Fein, M.D., today presented new research showing that patients with Cushing's syndrome, a rare disease that can lead to extreme weight gain, type 2 diabetes, high blood pressure and psychological issues, experienced significant, sustained weight loss while taking oral medication daily over a number of years to manage symptoms of the disease. [More]
RYGB surgery can help reduce heart disease risk in obese patients with Type 2 diabetes

RYGB surgery can help reduce heart disease risk in obese patients with Type 2 diabetes

Obese patients with Type 2 diabetes who don't have excessive surgical risk may find that Roux-en-Y gastric bypass (RYGB) surgery can help them reduce their risk of heart disease, a new clinical trial shows. [More]
Engaging in physical activity before attempting weight loss helps protect MetS patients from muscle loss

Engaging in physical activity before attempting weight loss helps protect MetS patients from muscle loss

Younger and older women tend to lose lean muscle mass, along with fat, unless they engage in physical activity before they attempt weight loss, a new study from Israel finds. The results were presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago. [More]
Improved physical fitness reduces risk of CKD in patients with Type 2 diabetes

Improved physical fitness reduces risk of CKD in patients with Type 2 diabetes

Adults with Type 2 diabetes who improve their physical fitness lower their chances of getting chronic kidney disease (CKD), and if they already have kidney damage, they can improve their kidney function. [More]
Patients continue to lose bone at least 2 years after bariatric surgery, shows study

Patients continue to lose bone at least 2 years after bariatric surgery, shows study

A new study shows that for at least two years after bariatric surgery, patients continue to lose bone, even after their weight stabilizes. [More]
Adults with Type 2 diabetes achieve better blood glucose control after sleeve gastrectomy surgery

Adults with Type 2 diabetes achieve better blood glucose control after sleeve gastrectomy surgery

Adults with Type 2 diabetes achieve better blood glucose (sugar) control two years after undergoing laparoscopic sleeve gastrectomy than do patients who receive standard medical diabetes care without this weight loss surgery, a new study finds. [More]
Soy protein supplements do not reduce testosterone levels in men with Type 2 diabetes

Soy protein supplements do not reduce testosterone levels in men with Type 2 diabetes

Soy protein supplements, which contain natural estrogens, do not reduce testosterone levels in men with Type 2 diabetes who already have borderline-low testosterone, according to a new study. [More]
Auxogyn receives clearance from FDA for Eeva System

Auxogyn receives clearance from FDA for Eeva System

Auxogyn, Inc. a leader in women's reproductive health, today announced that its first product, the Eeva System, received clearance from the U.S. Food and Drug Administration through its de novo classification process, a regulatory pathway for select novel, low- to moderate-risk medical devices that are first-of-a-kind. [More]
Studies stress the importance of vitamin D intake during first year of life

Studies stress the importance of vitamin D intake during first year of life

Everyone seems to agree that vitamin D is important throughout life. This is certainly as true in the first year of life as it is later on. [More]
Experts from ProfNet network available to discuss timely issues in coverage area

Experts from ProfNet network available to discuss timely issues in coverage area

Below are experts from the ProfNet network that are available to discuss timely issues in your coverage area. If you are interested in interviewing any of the experts, please contact them via the contact information at the end of the listing. [More]
Parathyroid hormone with vitamin D may be needed to assess impact on sugar metabolism

Parathyroid hormone with vitamin D may be needed to assess impact on sugar metabolism

Combined assessment of parathyroid hormone along with vitamin D may be needed to assess the impact of vitamin D status on sugar metabolism, according to Toronto researchers. [More]
Sheffield professor awarded prestigious Camillo Golgi Prize for outstanding contribution to medicine

Sheffield professor awarded prestigious Camillo Golgi Prize for outstanding contribution to medicine

A CONSULTANT who first described how diabetic nerve damage is caused by impaired circulation of the nerves has been awarded one of the most coveted international prizes in medicine in recognition of his outstanding contribution to the field. [More]
RMANJ releases new fertility checklist for early diagnosis and treatment options

RMANJ releases new fertility checklist for early diagnosis and treatment options

With over seven million men and women in the United States impacted by infertility, information about early diagnosis and various infertility treatment options like in vitro fertilization (IVF), preimplantation genetic diagnosis (PGD), and comprehensive chromosome screening (CCS) can offer help to many patients looking to overcome infertility. [More]
Researchers reveal why Peel has one of highest rates of diabetes in Ontario

Researchers reveal why Peel has one of highest rates of diabetes in Ontario

According to researchers at St. Michael's Hospital, there are two significant reasons why Peel has one of the highest rates of diabetes in Ontario: neighbourhood design that discourages walking and a population with many residents whose ethnic backgrounds predispose them to diabetes. [More]
Combination therapy with MEK and BRAF inhibitors for anaplastic thyroid cancer proves effective

Combination therapy with MEK and BRAF inhibitors for anaplastic thyroid cancer proves effective

Researchers from the Jacks Laboratory at MIT's Koch Institute for Integrative Cancer Research (KI) have developed and characterized a genetically engineered mouse that successfully models progression from papillary thyroid cancer, which has an excellent prognosis, to anaplastic thyroid cancer (ATC), a highly lethal disease. [More]
Researchers discover hotspot L205R mutation is closely associated with adrenocortical tumors

Researchers discover hotspot L205R mutation is closely associated with adrenocortical tumors

Chinese researchers from Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, BGI, and other institutions have discovered that the activating hotspot L205R mutation in PRKACA gene was closely associated with adrenocortical tumors (ACTs), and the relationship of recurrently mutated DOT1L and CLASP2 with ACTs' other subtypes. [More]
Bariatric surgery patients report better quality of life

Bariatric surgery patients report better quality of life

A study by Cleveland Clinic researchers shows bariatric surgery is a highly effective and durable treatment for type 2 diabetes in obese patients, enabling nearly all surgical patients to be free of insulin and many to be free of all diabetic medications three years after surgery. [More]